Evidence map›Paper›PMID 42688214›Full record

ArticleFrontiers in pediatrics2026

Case Report:

Xiaobei Cao, Bo Wang, Yongsheng Xu

Abstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaobei CaoDepartment of Pediatric Respiratory Medicine, Tianjin Children's Hospital (Children's Hospital, Tianjin University), Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin, China.
Bo WangDepartment of Pediatric Respiratory Medicine, Tianjin Children's Hospital (Children's Hospital, Tianjin University), Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin, China.
Yongsheng XuDepartment of Pediatric Respiratory Medicine, Tianjin Children's Hospital (Children's Hospital, Tianjin University), Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hyper-IgE syndrome (HIES) is a rare primary immunodeficiency disorder distinguished by a triad of eczema, recurrent skin and pulmonary infections, and elevated serum IgE levels. The loss-of-function mutations in signal transducer and activator of transcription 3 ( Case presentation: This report describes two cases of children with STAT3-HIES. One case was a 3-year-old child who presented with intestinal intussusception as the initial symptom and was considered to have probable intestinal tuberculosis and accompanied by miliary pulmonary tuberculosis, and tuberculosis was cured after one year of anti-infection treatment, HIES combined with intestinal tuberculosis presenting with intussusception as the clinical manifestation has never been reported. Second case was a 16-year-old child who was diagnosed with anaplastic lymphoma kinase-negative anaplastic large cell lymphoma because of swollen lymph nodes in the neck at the age of 10, he underwent allogeneic hematopoietic stem cell transplantation when he was 16 years old, unfortunately he died of lung infection after three months. Conclusion: The cases described in this article enhance our understanding of the manifestations, treatment and prognosis of this syndrome, highlighting the hazards of active tuberculosis and lymphoma in patients with HIES, as well as the importance of timely diagnosis, individualized treatment and follow-up.

Indexed as

hyper-IgE syndromeintestinal tuberculosislymphomamiliary pulmonary tuberculosisSTAT3

Identifiers

PMID42688214
PMCPMC13534057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.